SCHEMBL4743516

SCHEMBL4743516

CCC1COC(=O)C1CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.53
LMNA P02545 3/20 0.53
CYP2C9 P11712 3/20 0.53
CHRM4 P08173 2/20 0.53
CHRM5 P08912 2/20 0.53
CHRM1 P11229 2/20 0.53
CHRM3 P20309 2/20 0.53
CYP1A2 P05177 2/20 0.53
MAPK1 P28482 2/20 0.53
CYP2C19 P33261 2/20 0.53
CHRM2 P08172 1/20 0.53
CYP2A6 P11509 1/20 0.53
CNR1 P21554 1/20 0.53
HTR2A P28223 1/20 0.53
CYP2A13 Q16696 1/20 0.53
MEN1 O00255 1/20 0.53
USP2 O75604 1/20 0.53
TP53 P04637 1/20 0.53
ALOX15 P16050 1/20 0.53
ALOX12 P18054 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10203908 0.87 CYP3A4 (0.50) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL29155970 0.85 CYP3A4 (0.49) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL30799408 0.82 CYP3A4 (0.47) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL23053198 0.81 CYP3A4 (0.42) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL30799257 0.81 CYP3A4 (0.46) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL29159495 0.81 CYP3A4 (0.46) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL29159496 0.81 CYP3A4 (0.46) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL29159497 0.81 CYP3A4 (0.46) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL8499823 0.79 CYP3A4 (0.38) CYP3A4LMNACYP2C9CHRM4CHRM5
SCHEMBL8499825 0.79 CYP3A4 (0.38) CYP3A4LMNACYP2C9CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192699-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS Gritscience Biopharmaceuticals Co., Ltd. (CN) 2023-06-22 US disclosed
US-20230045851-A1 METHOD FOR PRODUCING RESIST COMPOSITION AND PATTERN FORMING METHOD FUJIFILM CORPORATION (JP) 2023-02-16 US disclosed
EP-3862815-A1 CHEMICAL LIQUID, CHEMICAL LIQUID HOUSING BODY, RESIST PATTERN FORMATION METHOD, AND PRODUCTION METHOD FOR SEMICONDUCTOR CHIPS FUJIFILM Corporation (JP) 2021-08-11 EP disclosed
US-20150378257-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, METHOD OF MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-12-31 US disclosed
US-8815490-B2 Radiation-sensitive resin composition, polymer, and method for forming resist pattern JSR CORPORATION (JP) 2014-08-26 US disclosed
US-20130189621-A1 RADIATION-SENSITIVE RESIN COMPOSITION, POLYMER AND COMPOUND JSR CORPORATION (JP) 2013-07-25 US disclosed
US-20110212401-A1 RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST PATTERN FORMATION METHOD JSR CORPORATION (JP) 2011-09-01 US disclosed
US-7575846-B2 Resist polymer and resist composition MITSUBISHI RAYON CO., LTD. (JP) 2009-08-18 US disclosed
WO-2008107365-A1 NEW COMPOUNDS MEDIVIR AB (SE) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192699-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS CSNK2A3, CSNK1A1, CSNK1G3 CYP3A4 1474/4885LMNA 2245/4885CYP2C9 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.